Top Markets
Coin of the day
GSK plc GSK plc

GSK plc

GSK
Classificação em ações #199
GSK plc, together with its subsidiaries, engages in the creation, discovery,... GSK plc, together with its subsidiaries, engages in the creation, discovery, development, manufacture, and marketing of pharmaceutical products, vaccines, over-the-counter medicines, and health-related consumer products in the United Kingdom, the United States, and internationally. It operates through four segments: Pharmaceuticals, Pharmaceuticals R&D, Vaccines, and Consumer Healthcare. The company offers pharmaceutical products comprising medicines in the therapeutic areas, such as respiratory, HIV, immuno-inflammation, oncology, anti-viral, central nervous system, cardiovascular and urogenital, metabolic, anti-bacterial, and dermatology. It also provides consumer healthcare products in wellness, oral health, nutrition, and skin health categories. The company offers its consumer healthcare products in the form of nasal sprays, tablets, syrups, lozenges, gum and trans-dermal patches, caplets, infant syrup drops, liquid filled suspension, wipes, gels, effervescents, toothpastes, toothbrushes, mouthwashes, denture adhesives and cleansers, topical creams and non-medicated patches, lip balm, gummies, and soft chews. It has collaboration agreements with 23andMe; Lyell Immunopharma, Inc.; Novartis; Sanofi SA; Surface Oncology; Progentec Diagnostics, Inc.; Alector, Inc.; and CureVac AG., as well as strategic partnership with IDEAYA Biosciences, Inc. and Vir Biotechnology, Inc. The company was formerly known as GlaxoSmithKline plc and changed its name to GSK plc in May 2022. GSK plc was founded in 1715 and is headquartered in Brentford, the United Kingdom.
Preço da ação
$51.99
Valor de mercado
$104.42B
Variação (1 dia)
0.29%
Variação (1 ano)
32.49%
País
GB
Negociar GSK plc (GSK)

Categoria

EPS de GSK plc (GSK)
EPS em December 2025 TTM: $3.82
De acordo com os últimos relatórios financeiros e o preço das ações da GSK plc, o EPS atual da empresa (TTM) é $3.82. No final de 2024, a empresa teve um EPS de $1.58, uma diminuição em relação a ao EPS de 2023, que foi de $3.11.
Histórico de EPS da GSK plc de 2000 até 2026
EPS no final de cada ano
Ano EPS Alterar
2026 (TTM) $3.82 2.94%
2025 $3.71 134.74%
2024 $1.58 -49.10%
2023 $3.11 5.22%
2022 $2.95 -20.32%
2021 $3.70 -5.92%
2020 $3.94 26.89%
2019 $3.10 32.40%
2018 $2.34 122.33%
2017 $1.05 77.94%
2016 $0.59 -90.78%
2015 $6.42 186.38%
2014 $2.24 -51.96%
2013 $4.67 25.18%
2012 $3.73 -8.24%
2011 $4.07 226.52%
2010 $1.25 -71.71%
2009 $4.40 35.82%
2008 $3.24 -31.08%
2007 $4.70 0.76%
2006 $4.67 31.64%
2005 $3.55 8.50%
2004 $3.27 -5.77%
2003 $3.47 29.66%
2002 $2.67 45.99%
2001 $1.83 -27.83%
2000 $2.54 0.00%
EPS de empresas semelhantes ou concorrentes
Empresa EPS Diferença de EPS País
$23.00 502.24%
US
$13.20 245.63%
GB
$11.10 190.64%
US
$2.37 -37.94%
US
$7.20 88.53%
CH